Keith Erdman
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 3
- Virology 3
- HIV Research and Treatment 3
- Co-authors
- G. Richard Granneman (4 shared papers)John M. Leonard (3 shared papers)Ann Hsu (3 shared papers)Eugene Sun (2 shared papers)Guoliang Cao (2 shared papers)Paolo Baroldi (1 shared paper)J.W.M. ter Berg (1 shared paper)Tawakol A. El‐Shourbagy (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Clinical Therapeutics (2 papers)Clinical Pharmacokinetics (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Keith Erdman
9 papers receiving 486 citations
Peers
Comparison fields: 5 of 66
- Virology 234
- Infectious Diseases 327
- Pharmacology 96
- Emergency Medicine 83
- Pediatrics, Perinatology and Child Health 111
Countries citing papers authored by Keith Erdman
This map shows the geographic impact of Keith Erdman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Erdman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Erdman more than expected).
Fields of papers citing papers by Keith Erdman
This network shows the impact of papers produced by Keith Erdman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Erdman. The network helps show where Keith Erdman may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Erdman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 158 | |
| 2 | 1998 | 135 | |
| 3 | 1998 | 130 | |
| 4 | 1995 | 24 | |
| 5 | 2000 | 16 | |
| 6 | 2005 | 16 | |
| 7 | 2002 | 15 | |
| 8 | 2013 | 6 | |
| 9 | 2007 | 4 |
About Keith Erdman
Keith Erdman is a scholar working on Infectious Diseases, Virology, Nephrology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 9 papers that have together received 504 indexed citations. Recurring topics across this work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Gastroesophageal reflux and treatments (2 papers), Pharmaceutical studies and practices (2 papers), Hepatitis C virus research (2 papers), Dysphagia Assessment and Management (1 paper) and Diabetes Treatment and Management (1 paper). The work is most often cited by research in Virology (234 citations), Infectious Diseases (327 citations), Pharmacology (96 citations), Emergency Medicine (83 citations) and Pediatrics, Perinatology and Child Health (111 citations). Keith Erdman has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include G. Richard Granneman, John M. Leonard, Ann Hsu, Eugene Sun, Guoliang Cao, Paolo Baroldi, J.W.M. ter Berg, Tawakol A. El‐Shourbagy, Anthony J. Japour and Nicholas A. Lyons. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Therapeutics, Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.